BROFEZIL
UNII E375EMI4HW

Substance Identification & Data

This profile provides standardized clinical and technical data for Brofezil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E375EMI4HW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 17969-45-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E375EMI4HW

CAS Registry Number

17969-45-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BROFEZIL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H10BrNO2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JGQKYWPSFPCKLW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C74329

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

189879

Unique identification number in the NCBI database of chemical substances.

INN ID

3606

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

s1c(nc(c1)-c2ccc(cc2)Br)C(C(=O)O)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brofezil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.